SM

Samrood Melepeediyekkal

Active Director Director DIN 11459142
DIN 11459142 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Samrood Melepeediyekkal

Data last updated:

Samrood Melepeediyekkal is a Director at Arcix Pharma Private Limited (since 2025).

DIN 11459142
Primary Designation Director
First Appointment 31 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arcix Pharma Private Limited U46497KL2025PTC099716
Director31 Dec 20252025Active

Board colleagues of Samrood Melepeediyekkal

NameDINCompanyDesignation
Afzal Rahman11459144Arcix Pharma Private LimitedDirector
Rahul11459141Arcix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arcix Pharma Private Limited
Premium access

Shareholding and investment profile for Samrood Melepeediyekkal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samrood Melepeediyekkal

Samrood Melepeediyekkal currently holds 1 directorship: Arcix Pharma Private Limited (Director, since 31 Dec 2025).

Samrood Melepeediyekkal was first appointed on 31 Dec 2025 as Director at Arcix Pharma Private Limited.

The current boards of Samrood Melepeediyekkal's companies include Afzal Rahman (Arcix Pharma Private Limited), Rahul (Arcix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available